Sildenafil citrate (Viagra®) for the treatment of erectile dysfunction in Nigerian men

Fifty-eight Nigerian outpatients with documented erectile dysfunction (ED) received open-label sildenafil citrate (Viagra ® ) for 8 weeks. The 50-mg starting dose could be adjusted to 100 or 25 mg based on response and tolerability. The International Index of Erectile Function (IIEF) Questionnaire,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of impotence research 2003-04, Vol.15 (Suppl 1), p.S15-S18
Hauptverfasser:	Osegbe, D N, Shittu, O B, Aghaji, A E, Onyemelukwe, G C, Dogo, D, Dikko, A A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Complications and side effects Dosage and administration Drug therapy Erectile dysfunction Erectile Dysfunction - drug therapy Humans Impotence Male Medicine Medicine & Public Health Middle Aged Nigeria Outpatients Piperazines - administration & dosage Piperazines - adverse effects Purines Reproductive Medicine Risk factors rology Sildenafil Sildenafil Citrate Sulfones Urology Vasodilator Agents - administration & dosage Vasodilator Agents - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Fifty-eight Nigerian outpatients with documented erectile dysfunction (ED) received open-label sildenafil citrate (Viagra ® ) for 8 weeks. The 50-mg starting dose could be adjusted to 100 or 25 mg based on response and tolerability. The International Index of Erectile Function (IIEF) Questionnaire, a global efficacy question, and intercourse data recorded in a patient event log were used to assess efficacy. Frequency of penetration and maintained erection were both significantly enhanced ( P
ISSN:	0955-9930 1476-5489
DOI:	10.1038/sj.ijir.3900972